BlackRock, Inc. 13D and 13G filings for ShockWave Medical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-24 2:27 pm Sale | 2023-12-31 | 13G | ShockWave Medical, Inc. SWAV | BlackRock Inc. BLK | 3,740,596 10.100% | -832,063 (-18.20%) | Filing |
| 2023-01-23 3:52 pm Purchase | 2022-12-31 | 13G | ShockWave Medical, Inc. SWAV | BlackRock Inc. BLK | 4,572,659 12.700% | 259,106 (+6.01%) | Filing |
| 2022-07-08 4:56 pm Purchase | 2022-06-30 | 13G | ShockWave Medical, Inc. SWAV | BlackRock Inc. BLK | 4,313,553 12.100% | 1,597,020 (+58.79%) | Filing |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | ShockWave Medical, Inc. SWAV | BlackRock Inc. BLK | 2,716,533 7.700% | 318,853 (+13.30%) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | ShockWave Medical, Inc. SWAV | BlackRock Inc. BLK | 2,397,680 7.000% | 2,397,680 (New Position) | Filing |